Treatments How It Works Team Pricing Hospitals About FAQ Consult Now
Home  /  Treatments  /  Liver Cancer

Liver Cancer Treatment in China

Surgical treatment from $15,000–35,000, coordinated at high-volume hepatobiliary centers — with Guangzhou typically at the lower end of the range.

Liver cancer treatment facility in China
The Basics

How liver cancer is treated

Primary liver cancer (hepatocellular carcinoma, HCC) is one of the most common cancers in China, largely because of the country’s high historical prevalence of hepatitis B. That burden is also why Chinese hepatobiliary centers operate and treat at a volume few countries can match, and why treatment protocols here are mature across the full range of stages — resection, local ablation, transarterial chemoembolisation (TACE), radiotherapy and systemic therapy.

Treatment is staged rather than fixed: a small tumour in a well-preserved liver may be treated with ablation or a limited resection, an intermediate-stage tumour with TACE, and an advanced tumour with targeted or immunotherapy-based systemic treatment. Because so much depends on liver function, tumour number, size and vascular involvement, a written plan from a hepatobiliary multidisciplinary team matters more here than in almost any other tumour type.

Honest boundary: which option applies to a specific patient is determined by a multidisciplinary team reviewing imaging, liver function and prior treatment. We coordinate that review and the logistics around it; we do not choose the treatment and we cannot promise any outcome.
Who It May Be Evaluated For

Commonly reviewed indications

Hepatobiliary departments commonly evaluate:

Resectable HCC

Tumours confined to the liver with adequate residual liver function, assessed for anatomical resection.

Small tumours

Local ablation (radiofrequency or microwave), sometimes as a bridge to transplantation assessment.

Intermediate-stage disease

Transarterial chemoembolisation (TACE), alone or combined with systemic therapy.

Advanced or metastatic disease

Systemic therapy including targeted agents and checkpoint inhibitors, at China pricing.

Costs

What liver cancer treatment costs in China

Cost depends on the modality chosen, so the table separates surgery from other pathways:

ItemChina (international dept.)United States (reference)
Liver resectionsurgery and hospital stay$15,000 – 35,000$78,000 – 111,000
median hospital charges, open vs. laparoscopic
Guangzhou centerssame procedure, lower city factor$15,000 – 24,000city-comparison not applicable — the US reference above is the national figure
Ablation or TACEper sessionquoted in the hospital’s written estimate$15,000 – 50,000
ablation $15,000–40,000; TACE $20,000–50,000 per session, several sessions common
Systemic therapyper cycle, drugs includedquoted in the hospital’s written estimate$8,000 – 15,000
per 3-week immunotherapy-based cycle at US list prices ($120,000–250,000 per year)
Source and scope: surgical range compiled from city-level international-patient quotes; systemic-therapy pricing in China is materially below US list prices for the same agents, but is quoted per protocol. For the US reference, median hospital charges for liver resection were $111,051 for the open approach and $77,657 for laparoscopic resection, in 2020 dollars, including 30-day readmissions (Alizai et al., Surgery 2026; Nationwide Readmissions Database 2016–20). Last checked 2025–26. These are indicative reference ranges compiled from published hospital fees, public procurement prices and international-patient quotes. They are not quotations: the written estimate you receive from the treating hospital is the final number. Scope, implant choice, ward class and length of stay all move the figure.
Published Outcomes

How do the results compare?

Fudan University Zhongshan Hospital runs the world's largest liver-surgery program — and it has published 62 years of continuous follow-up data on 26,713 liver-cancer resections, first disclosed internationally in the hospital-led Lancet report on liver cancer:

Cohort5-year overall survivalComparison
Zhongshan Hospital, 2011–2020 resections26,713-patient series since 195870.7%
10-year survival 57.8% — up from 10.1% in 1958–1980
Japan national registry, 35,000+ surgical patients: 5-year overall survival 69.1%
Zhongshan Hospital, curative resectionshospital-published figure5-year survival 68%
nearly 3,500 patients alive beyond 10 years
Largest US centers: a few hundred liver resections per year, vs 4,000+ at Zhongshan
Sources: Fudan University Zhongshan Hospital clinical publications and official hospital data (62-year, 26,713-patient series, 1958–2020), disclosed in the Lancet liver-cancer report led by the Zhongshan team (2025); Japanese national registry data as cited in Clinical Advances (2025) review. Both figures are surgical-cohort outcomes — not a head-to-head comparison: hepatitis-B-related disease dominates in China while metabolic and hepatitis-C disease dominates in Japan, and patient selection differs. Individual results vary, and survival statistics are not a guarantee of outcome.
The Journey

How we coordinate a liver cancer case

1
Initial Case Review

You send imaging (CT/MRI), pathology, liver function results and any prior treatment history; we confirm which hepatobiliary centers fit the case.

2
Costs confirmed in writing

Your records are presented to suitable departments, and you receive written treatment plans and estimates before committing to anything.

3
Travel & admission

Visa invitation letter, flights and accommodation near the hospital are arranged before you fly.

4
Multidisciplinary review

The treating team reviews staging and liver function on site and confirms the recommended modality with you through an interpreter.

5
Treatment

Resection, ablation, TACE or the start of systemic therapy, with inpatient or day-case monitoring as required.

6
Discharge & follow-up planning

Interpreter-supported discharge, English documents where the hospital provides them, and a surveillance plan that can be continued at home.

Related

Where to go next

Heavy-ion therapy →

Carbon-ion radiotherapy for selected liver lesions, from $35,000 per course.

Full price list →

Reference ranges for all treatments, side-by-side with US prices.

How it works →

The six-step process from first inquiry to follow-up, with fee timing.

Have imaging and a diagnosis confirmed?

Send the reports and we will tell you which hepatobiliary centers can review the case — and what the written estimates look like.